These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15357964)

  • 21. Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.
    Tian X; Switzer AG; Derose SA; Mishra RK; Solinsky MG; Mumin RN; Ebetino FH; Jayasinghe LR; Webster ME; Colson AO; Crossdoersen D; Pinney BB; Farmer JA; Dowty ME; Obringer CM; Cruze CA; Burklow ML; Suchanek PM; Dong L; Dirr MK; Sheldon RJ; Wos JA
    J Med Chem; 2008 Oct; 51(19):6055-66. PubMed ID: 18771254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor.
    Tran JA; Pontillo J; Arellano M; Fleck BA; Tucci FC; Marinkovic D; Chen CW; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3434-8. PubMed ID: 15950470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
    Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrrolidines as potent functional agonists of the human melanocortin-4 receptor.
    Tran JA; Chen CW; Jiang W; Tucci FC; Fleck BA; Marinkovic D; Arellano M; Chen C
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5165-70. PubMed ID: 17629702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity.
    He S; Ye Z; Dobbelaar PH; Bakshi RK; Hong Q; Dellureficio JP; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Reibarkh M; Holmes MA; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6524-32. PubMed ID: 20933410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonists.
    Bakshi RK; Hong Q; Olson JT; Ye Z; Sebhat IK; Weinberg DH; MacNeil T; Kalyani RN; Tang R; Martin WJ; Strack A; McGowan E; Tamvakopoulos C; Miller RR; Stearns RA; Tang W; Maclntyre DE; van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3430-3. PubMed ID: 15951175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of cyclic peptides with agonist activity at melanocortin receptor-4.
    Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3723-6. PubMed ID: 16678415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivatives.
    Briner K; Collado I; Fisher MJ; García-Paredes C; Husain S; Kuklish SL; Mateo AI; O'Brien TP; Ornstein PL; Zgombick J; de Frutos O
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3449-53. PubMed ID: 16650763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
    Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
    Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human beta-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV.
    Hsiung HM; Smiley DL; Zhang XY; Zhang L; Yan LZ; Craft L; Heiman ML; Smith DP
    Peptides; 2005 Oct; 26(10):1988-96. PubMed ID: 15985311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the structure-activity relationship of the basic amine of phenylpiperazines as melanocortin-4 receptor antagonists.
    Tran JA; Arellano M; Fleck BA; Pontillo J; Marinkovic D; Tucci FC; Wen J; Saunders J; Chen C
    Med Chem; 2008 Jan; 4(1):67-74. PubMed ID: 18220971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and SAR studies on a series of 2-pyridinylpiperazines as potent antagonists of the melanocortin-4 receptor.
    Tran JA; Pontillo J; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Saunders J; Jiang W; Chen CW; Foster AC; Chen C
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3693-6. PubMed ID: 16697187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor.
    Tran JA; Jiang W; Tucci FC; Fleck BA; Wen J; Sai Y; Madan A; Chen TK; Markison S; Foster AC; Hoare SR; Marks D; Harman J; Chen CW; Arellano M; Marinkovic D; Bozigian H; Saunders J; Chen C
    J Med Chem; 2007 Dec; 50(25):6356-66. PubMed ID: 17994683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives.
    Kuklish SL; Backer RT; Briner K; Doecke CW; Husain S; Mullaney JT; Ornstein PL; Zgombick JM; O'Brien TP; Fisher MJ
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3843-6. PubMed ID: 16697186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.
    Hong Q; Bakshi RK; Palucki BL; Park MK; Ye Z; He S; Pollard PG; Sebhat IK; Liu J; Guo L; Cashen DE; Martin WJ; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; MacIntyre DE; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2330-4. PubMed ID: 21439820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.
    Nozawa D; Okubo T; Ishii T; Kakinuma H; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2007 Mar; 15(5):1989-2005. PubMed ID: 17234422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands.
    Bakshi RK; Hong Q; Tang R; Kalyani RN; Macneil T; Weinberg DH; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1130-3. PubMed ID: 16364639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity.
    He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Weinberg DH; Macneil T; Tang R; Strack AM; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4399-405. PubMed ID: 20598882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propionylpiperazines as human melanocortin-4 receptor ligands.
    Chen CW; Tran JA; Jiang W; Tucci FC; Arellano M; Wen J; Fleck BA; Marinkovic D; White NS; Pontillo J; Saunders J; Madan A; Foster AC; Chen C
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4800-3. PubMed ID: 16824757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.